Back
Genelux Corporation GNLX · Insights
Genelux Corporation is a clinical-stage biopharmaceutical company focused on pioneering advanced onc... Price2.07
Market Cap93.66 M
Float44.26 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro